Back
| Name | di-Sodium Hydrogen Phosphate 12-hydrate (USP, BP, Ph. Eur.) |
| Grade | pharma |
| Purity | low in endotoxins |
| Physical Form | powder |
| Color | white |
| Solubility | soluble in water |
| Storage Condition | store in a cool, dry place |
| Shelf Life | minimum 2 years |
| Molecular Weight | 358.14 g/mol |
| CAS Number | 10039-32-4 |
| Molecular Formula | Na2HPO4 * 12H2O |
| Package Size | available in various pack sizes |
FAQ
What is di-Sodium Hydrogen Phosphate 12-hydrate (USP, BP, Ph. Eur.) and what are its
pharmaceutical grade specifications?
Di-Sodium Hydrogen Phosphate 12-hydrate, also known as disodium phosphate, is a compound widely used in the pharmaceutical industry. It meets the standards set by the United States Pharmacopeia (USP), British Pharmacopoeia (BP), and European Pharmacopoeia (Ph. Eur.), ensuring its quality and purity for pharmaceutical applications. This product is low in endotoxins and meets the requirements for pharmaceutical grade materials.
What are the benefits of using di-Sodium Hydrogen Phosphate 12-hydrate (USP, BP, Ph. Eur.) for pharmaceutical applications?
Di-Sodium Hydrogen Phosphate 12-hydrate has a range of benefits for pharmaceutical applications. It serves as a buffering agent, helping to maintain the pH of solutions within a desired range. Additionally, it can be used as a stabilizer in pharmaceutical formulations, ensuring the integrity of the product. Its low endotoxin levels make it suitable for use in sterile preparations, further enhancing its value in pharmaceutical applications.
How is di-Sodium Hydrogen Phosphate 12-hydrate (USP, BP, Ph. Eur.) manufactured and what quality control measures are in place to ensure its purity?
Di-Sodium Hydrogen Phosphate 12-hydrate is manufactured using high-quality raw materials and state-of-the-art production processes. Stringent quality control measures are in place throughout the manufacturing process to ensure the purity and consistency of the product. Batch testing is conducted to verify that the product meets the specifications outlined in the USP, BP, and Ph. Eur. monographs for pharmaceutical grade materials.
In what forms is di-Sodium Hydrogen Phosphate 12-hydrate (USP, BP, Ph. Eur.) available and how can it be used in pharmaceutical formulations?
Di-Sodium Hydrogen Phosphate 12-hydrate is available in various forms, including powder and granules, making it versatile for use in pharmaceutical formulations. It can be dissolved in water to create solutions or added directly to formulations as a solid ingredient. The compound is compatible with a wide range of excipients and can be used in a variety of pharmaceutical dosage forms, such as tablets, capsules, and injectable solutions.
What sets di-Sodium Hydrogen Phosphate 12-hydrate (USP, BP, Ph. Eur.) apart as a pharmaceutical grade material and why should it be considered for use in pharmaceutical manufacturing?
Di-Sodium Hydrogen Phosphate 12-hydrate stands out as a pharmaceutical grade material due to its purity, low endotoxin levels, and adherence to stringent quality standards. It is a reliable ingredient that can enhance the stability, safety, and efficacy of pharmaceutical formulations. Pharmaceutical manufacturers can trust in the quality and consistency of di-Sodium Hydrogen Phosphate 12-hydrate to meet the demanding requirements of pharmaceutical production.
Di-Sodium Hydrogen Phosphate 12-hydrate, also known as disodium phosphate, is a compound widely used in the pharmaceutical industry. It meets the standards set by the United States Pharmacopeia (USP), British Pharmacopoeia (BP), and European Pharmacopoeia (Ph. Eur.), ensuring its quality and purity for pharmaceutical applications. This product is low in endotoxins and meets the requirements for pharmaceutical grade materials.
What are the benefits of using di-Sodium Hydrogen Phosphate 12-hydrate (USP, BP, Ph. Eur.) for pharmaceutical applications?
Di-Sodium Hydrogen Phosphate 12-hydrate has a range of benefits for pharmaceutical applications. It serves as a buffering agent, helping to maintain the pH of solutions within a desired range. Additionally, it can be used as a stabilizer in pharmaceutical formulations, ensuring the integrity of the product. Its low endotoxin levels make it suitable for use in sterile preparations, further enhancing its value in pharmaceutical applications.
How is di-Sodium Hydrogen Phosphate 12-hydrate (USP, BP, Ph. Eur.) manufactured and what quality control measures are in place to ensure its purity?
Di-Sodium Hydrogen Phosphate 12-hydrate is manufactured using high-quality raw materials and state-of-the-art production processes. Stringent quality control measures are in place throughout the manufacturing process to ensure the purity and consistency of the product. Batch testing is conducted to verify that the product meets the specifications outlined in the USP, BP, and Ph. Eur. monographs for pharmaceutical grade materials.
In what forms is di-Sodium Hydrogen Phosphate 12-hydrate (USP, BP, Ph. Eur.) available and how can it be used in pharmaceutical formulations?
Di-Sodium Hydrogen Phosphate 12-hydrate is available in various forms, including powder and granules, making it versatile for use in pharmaceutical formulations. It can be dissolved in water to create solutions or added directly to formulations as a solid ingredient. The compound is compatible with a wide range of excipients and can be used in a variety of pharmaceutical dosage forms, such as tablets, capsules, and injectable solutions.
What sets di-Sodium Hydrogen Phosphate 12-hydrate (USP, BP, Ph. Eur.) apart as a pharmaceutical grade material and why should it be considered for use in pharmaceutical manufacturing?
Di-Sodium Hydrogen Phosphate 12-hydrate stands out as a pharmaceutical grade material due to its purity, low endotoxin levels, and adherence to stringent quality standards. It is a reliable ingredient that can enhance the stability, safety, and efficacy of pharmaceutical formulations. Pharmaceutical manufacturers can trust in the quality and consistency of di-Sodium Hydrogen Phosphate 12-hydrate to meet the demanding requirements of pharmaceutical production.
